REGENEVIA BIO
Advancing the Science of Human Longevity
“Extending the limits of human life and transcending the boundaries of our planet of origin are two inevitable steps toward the next stage in the evolution of our species.”
— Giorgio S. C. Linchi
Our Mission
At REGENEVIA BIO, we are committed to advancing the frontiers of biotechnology through rigorous research and innovation. Our focus on epigenetics and tissue rejuvenation underpins our dedication to enhancing health and well-being.
We strive to build a sustainable future by developing products that restore vitality and improve quality of life. Our vision is to lead the industry in ethical biotechnology solutions that empower individuals to achieve their fullest potential.
Born from over a decade of fundamental research into biological information, order, and organization, REGENEVIA represents the convergence of scientific rigor and visionary ambition.
Intellectual Property Portfolio
Protected Innovation — USPTO Patent Applications
- System of Aging Reversal in an Adult Human BeingA comprehensive method for epigenetic rejuvenation through controlled modulation of biological age markers.
- Autologous 3D Micro-Tissue Generation SystemAdvanced tissue engineering using patient-derived biological materials for regenerative applications.
- Personalized Autologous Serum for Skin RejuvenationIndividualized biological formulations for targeted dermal renewal and anti-aging therapy.
- Biologically Active Autologous FillersNext-generation biocompatible fillers capable of reconstructing joints and degenerated tissues using stem cells.
- Genesis7 – Systemic Autologous SerumA systemic approach to whole-body biological rejuvenation through autologous serum technology.
Core Capabilities
Innovative Solutions
Cutting-edge solutions merging science and technology for safe and effective rejuvenation applications.
Ethical Commitment
Integrity in research and commercialization, building trust with partners and clients worldwide.
IP Commercialization
Transforming innovative ideas into marketable products, ensuring intellectual property reaches its full potential.
Scientific Content
High-quality scientific publications facilitating knowledge dissemination and partner engagement.
Research Partnerships
Collaborating with stakeholders to advance epigenetic research and drive better outcomes in biotechnology.
Strategic Alliances
Building strategic partnerships to amplify impact and drive forward the next wave of biotech innovation.
The Lynch Group Vision
Three Entities — One Unified Scientific Framework
REGENEVIA BIO
Epigenetic rejuvenation and tissue regeneration. Focused on reversing biological aging through protected, innovative methodologies.
Each entity within Lynch Group operates independently, with distinct governance, funding structures, and research objectives.
Long Life Genetics
Over a decade of fundamental longevity research, coordinating with 1,500+ research institutes worldwide in a unique distributed model.
The foundational research platform supporting the Group’s long-term longevity science initiatives.
GENATLANTICA LIFE SCIENCES
GenAtlantica Life Sciences is the European company of the Group, responsible for the development, production oversight, and commercialization of GenAtlantica products within the European market.
Operating from the European Union, the company ensures full compliance with all applicable sector regulations, quality standards, and consumer protection requirements. GenAtlantica Life Sciences combines scientific innovation with regulatory rigor, delivering advanced longevity solutions developed and distributed in strict accordance with European law.
Our Scientific Advisory
Expert guidance in regenerative therapies
Innovative insights in epigenetics
Anti-Age strategy
Image & Marketing Strategy
Partner With Us
We are actively seeking strategic partners, investors, and research collaborators who share our vision of extending human healthspan through rigorous science.